No Picture
Los Angeles Biotech News

Older Adults Who Receive Additional Supportive Care Services Experience Fewer Side Effects From Chemotherapy, City of Hope Study Finds

DUARTE, Calif.–(BUSINESS WIRE)–Study: Patients over 65 receiving chemotherapy experienced fewer side effects when a team of experts analyzed each case and introduced interventions. […]

No Picture
Los Angeles Biotech News

Dermavant Showcases New Long-Term Data from Phase 3 PSOARING 3 Trial of Tapinarof in Patients with Plaque Psoriasis at the 30th EADV Virtual Congress

LONG BEACH, Calif., & BASEL, Switzerland–(BUSINESS WIRE)–Dermavant Showcases New Long-Term Data from Phase 3 PSOARING 3 Trial of Tapinarof in Patients with Plaque Psoriasis at the 30th EADV Virtual Congress […]

No Picture
Los Angeles Biotech News

AbbVie, industry group push for international compromise on when trial investigators should receive unblinded data

AbbVie and industry group TransCelerate Biopharma are taking issue with the FDA’s attempt to change when certain IND safety reports should be unblinded. Back in June, the FDA released a new draft guidance that lays out when certain safety reports shoul… […]

No Picture
Los Angeles Biotech News

ImmixBio Announces FDA Orphan Drug Designation for IMX-110 for the Treatment of Soft Tissue Sarcoma

LOS ANGELES: LOS ANGELES, Sept. 30, 2021 /PRNewswire/ — Immix Biopharma, Inc. ("ImmixBio"), a biotechnology company pioneering Tissue Specific Therapeutics (TSTx)TM for oncology and inflammation, today announced that the U.S. Food and Drug A… […]

No Picture
Los Angeles Biotech News

Alexandria Real Estate Equities, Inc. Deepens and Expands Strategic Relationship With Moderna for New 462,000 RSF HQ and R&D Facility at 325 Binney Street, Designed to Be the Most Sustainable Laboratory Building in Cambridge

PASADENA, Calif. and CAMBRIDGE, Mass.: PASADENA, Calif. and CAMBRIDGE, Mass., Sept. 30, 2021 /PRNewswire/ — Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and devel… […]